Lysosomal Oxidative Stress Cytotoxicity Induced by Dacarbazine and It’s Pyridine Derivative in Hepatocytes Dacarbazine induced lysosomal oxidative stress
Iranian Journal of Pharmaceutical Sciences,
Vol. 2 No. 4 (2006),
1 October 2006
,
Page 195-202
https://doi.org/10.22037/ijps.v2.40321
Abstract
Dacarbazine (DTIC) is a synthetic chemical antitumor agent which is used to treat malignant melanoma and Hodgkin’s disease. DTIC is a prodrug which is converted to an active form undergoing demethylation by liver enzymes. The active form prevents the progress of disease via alkylation of DNA strand. In the structure of this drug, the imidazole ring, a triazen chain and carboxamide group exist. Based on the literature, the ring and carboxamide group do not have a key role in antitumor activity of the drug. On the other hand, imidazole ring has a unique tautomerization which may participate in the mechanism of action of DTIC and carboxamide group may determine the rich guanine pieces in DNA strand. In order to investigate the mechanistic role of imidazole group and its known tautomerization in DTIC cytotoxicity, derivative of DTIC with a pyridine ring (3-(3,3-dimethyl-1-triazenyl)pyridine, (compound I) instead of imidazole ring was synthesized. In the following, the cellular and molecular mechanism of cytotoxicity induced by DTIC and its pyridine derivative toward the isolated rat hepatocytes were studied and compared. Hepatocyte reactive oxygen species (ROS) generation was significantly increased by both DTIC and compound B before cytotoxicity ensued. In addition, DTIC and compound I induced lysosomal damage and hepatocyte protease activation. Endocytosis inhibitors, lysosomotropic agents or lysosomal protease inhibitors
also prevented both DTIC and compound B induced hepatocytes cytotoxicity. Furthermore desferoxamine (a ferric chelator), antioxidants or ROS scavengers (catalase, mannitol or dimethylsulfoxide) prevented both DTIC and compound I cytotoxicity. It is concluded that H2O2 reacts with lysosomal Fe2+ to form hydroxyl radical which (Haber-Weiss reaction) causes lysosomal membrane disruption, proteases and other digestive enzymes release and finally the cell death.
- Cytochrome P450
- Cytotoxicity
- Dacarbazine
- Lysosomes Oxidative stress
- Tautomerization
How to Cite
References
[2] Yamagata S, Ohmori S, Suzuki N, Yoshino M, Hino M, Ishii I, Kitada M. Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine Ndemethylation. Drug Metab Dispos 1998; 26: 379-82.
[3] Costanzi JJ. DTIC (NSC-45388) studies in the southwest oncology group. Cancer Treat Rep1976; 60: 189-92.
[4] Saunders PP, Schultz GA. Studies of the mechanism of action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4(5)-carboxamide in Bacillus subtilis. Biochem Pharmacol 1970; 19: 911-9.
[5] http://www.drugs.com/pdr/DACARBAZINE.html (accessed on Nov. 26, 2005).
[6] Long L, Dolan ME. Role of cytochrome P450 isoenzymes in metabolism of O-(6)-benzylguanine: implications for dacarbazine activation. Clin Cancer Res 2001; 7: 4239-44.
[7] Skibba JL, Bryan GT. Methylation of nucleic acids and urinary excretion of 14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole5(4)-carboxomide. Toxicol Appl Pharmacol 1971; 18: 707-19.
[8] Skibba JL, Ramirez G, Beal DD, Bryan GT. Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man. Biochem Pharmacol 1970; 19: 2043-51.
[9] Mizuno NS, Humphrey EW. Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamie (NSC-45388) in human and animal tumor tissue. Cancer Chemother Rep 1972; 56: 465-72.
[10] Mizuno NS, Decker RW, Zakis B. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Biochem Pharmacol 1975; 24: 615-9.
[11] Pourahmad J, O'Brien PJ. A comparison of hepatocyte cytotoxic mechanisms for Cu2+ and Cd2+. Toxicology 2000; 143: 263-73.
[12] Pourahmad J, O'Brien PJ, Jokar F, Daraei B. Carcinogenic metal induced sites of reactive oxygen species formation in hepatocytes. Toxicol In Vitro 2003; 17: 803-10.
[13] Shen HM, Shi CY, Shen Y, Ong CN. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Rad Biol Med 1996; 21: 139-46.
[14] Pourahmad J, Ross S, O'Brien PJ. Lysosomal involvement in hepatocyte cytotoxicity induced by Cu2+ but not Cd2+. Free Rad Biol Med 2001; 30: 89-97.
[15] Siraki AG, Pourahmad J, Chan TS, Khan S, O'Brien PJ. Endogenous and endobiotic induced reactive oxygen species formation by isolated hepatocytes. Free Rad Biol Med 2002; 32: 2-10.
[16] Hallinan T, Gor J, Rice-Evans CA, Stanley R, O'Reilly R, Brown D. Lipid peroxidation in electroporated hepatocytes occurs much more readily than does hydroxyl-radical formation. Biochem J 1991; 277: 767-71.
[17] Graham RM, Morgan EH, Baker E. Characterisation of citrate and iron citrate uptake by cultured rat hepatocytes. J Hepatol 1998; 29: 603-13.
[18] Luiken JJ, Aerts JM, Meijer AJ. The role of the intralysosomal pH in the control of autophagic proteolytic flux in rat hepatocytes. Eur J Biochem 1996; 235: 564-73.
[19] Brunk UT, Zhang H, Dalen H, Ollinger K. Exposure of cells to nonlethal concentrations of hydrogen peroxide induces degeneration-repair mechanisms involving lysosomal destabilization. Free Rad Biol Med 1995; 19: 813-22.
[20] Seglen PO. DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival. Cell Biol Toxicol 1997; 13:301-15.
- Abstract Viewed: 78 times
- IJPS_Volume 2_Issue 4_Pages 195-202 Downloaded: 15 times